Why the study?
Does overexpression of IGFBP-4 delay tumor formation and enhance apoptosis in malignant prostate epithelial cells?
Population
Malignant M12 prostate epithelial cell line and male athymic/nude mice
Comparison
Overexpression of the IGF-inhibitory IGFBP-4 vs Control cells (M12 controls)
Design
Preclinical
Authors
Loading...
Does not alter prostate cancer management; leaves open IGFBP-4 as a target for further preclinical validation.
Does overexpression of IGFBP-4 delay tumor formation and enhance apoptosis in malignant prostate epithelial cells?
Overexpression of the inhibitory IGFBP-4 delays the growth of malignant prostate epithelial cells and enhances their sensitivity to apoptosis in preclinical models.
Damon et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: